Actively Recruiting
Assessment of LC16m8 Mpox Vaccine Effectiveness and Safety in Individuals Aged One Year and Older in the Democratic Republic of Congo
Led by International Vaccine Institute · Updated on 2026-08-31
11990
Participants Needed
1
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness and safety of the LC16m8 vaccine against mpox monkeypox in individuals aged one year and older in the Democratic Republic of Congo DRC. This health facility-based study uses a test-negative case-control design to assess vaccine protection and includes active safety monitoring and passive surveillance. Community engagement, enhanced disease surveillance, and vaccination are key components of the research. Participants will receive the LC16m8 vaccine following the DRCs national vaccination strategy in selected hotspot areas. Vaccination records, along with biometric data when consented, will be collected and stored securely. Safety monitoring includes active follow-up for serious and special adverse events through phone calls, home visits, and health facility visits for up to 12 weeks post-vaccination, as well as passive surveillance at health facilities throughout the study duration. Participants will be enrolled when presenting to sentinel health facilities with suspected mpox symptoms and tested using RT-PCR on skin or oropharyngeal swabs. Researchers will collect clinical data, assess vaccine status, and monitor adverse events. Vaccine effectiveness will be determined by comparing vaccinated and unvaccinated individuals who test positive or negative for mpox. The study includes regular data collection, statistical analyses, and long-term follow-up, with the entire participation lasting up to the studys completion in 2027.
CONDITIONS
Brief Title
Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC)
Research Team
B
Birkneh Tilahun Tadesse, MD
M
Meseret Behute, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here